Table 6.
OS | PFS | |||
---|---|---|---|---|
HR (95%CI) | p value | HR (95%CI) | p value | |
Histogram-based | ||||
MTV (≥66.5 vs. <66.5) | 26.152 (2.089–327.392) | 0.011 ∗ | — | — |
Kurtosis (≥2.9179 vs. <2.9179) | 28.685 (2.067–398.152) | 0.012 ∗ | — | — |
| ||||
GLRLM | ||||
GLNU (≥178.7649 vs. <178.7649) | — | — | 14.642 (2.661–80.549) | 0.002 ∗ |
MTV, metabolic tumor volume; GLNU, gray-level nonuniformity; GLRLM, gray-level run length matrix; PFS, progression-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval. Asterisk (∗) indicates significance with a p value of <0.05 (shown in bold).